Transcripts NFL Biosciences

Stocks

Market Closed - Euronext Paris 16:55:00 29/09/2026 BST			5-day change	1st Jan Change
0.7300 ^EUR	+0.27%		-0.82%	-38.03%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI